Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication-Reference-Cited by-同舟云学术

Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication

Published:2021-06-26 Issue:1 Volume:88 Page:138-144
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Huh Ki Young¹,Chung Hyewon²,Kim Yu Kyong³,Lee SeungHwan¹,Bhatia Siddharth⁴,Takanami Yohei⁵,Nakaya Ryou⁵,Yu Kyung‐Sang¹^ORCID

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics Seoul National University College of Medicine and Hospital Seoul Republic of Korea

2. Department of Clinical Pharmacology and Toxicology Korea University Guro Hospital Seoul Republic of Korea

3. Department of Clinical Pharmacology and Therapeutics Chungbuk National University Hospital Chungcheongbuk‐do Republic of Korea

4. Takeda Pharmaceuticals International Co. Cambridge MA USA

5. Takeda Pharmaceutical Company Limited Osaka Japan

Funder

Takeda Pharmaceutical Company

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14934

Reference38 articles.

1. Peptic ulcer disease

2. The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer

3. Changing Trends in Stomach Cancer Throughout the World

4. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis

5. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of Vonoprazan-based treatment of Helicobacter pylori infection: a systematic review and network meta-analysis;BMC Infectious Diseases;2024-09-11

2. Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial;Helicobacter;2024-09

3. Efficacy and Safety of Vonoprazan-Based Quadruple Therapy for the Eradication of <i>Helicobacter pylori</i> in Patients with Peptic Ulcers: A Pooled Analysis of Two Randomized, Double-Blind, Double-Dummy, Phase 3 Trials;Biological and Pharmaceutical Bulletin;2024-08-01

4. Vonoprazan‐based therapies versus PPI‐based therapies in patients with H. pylori infection: Systematic review and meta‐analyses of randomized controlled trials;Helicobacter;2024-05

5. Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial;BMC Gastroenterology;2024-04-12